Loading...
Eurofins Scientific SE
ERFSF•PNK
HealthcareMedical - Diagnostics & Research
$67.36
$0.008(0.01%)
Eurofins Scientific SE (ERFSF) Financial Performance & Statements
Review Eurofins Scientific SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.70%
↑ 6.70%
Operating Income Growth
-100.00%
↓ 100.00%
Net Income Growth
30.97%
↑ 30.97%
Operating Cash Flow Growth
29.57%
↑ 29.57%
Operating Margin
14.56%
↑ 14.56%
Gross Margin
15.42%
↑ 15.42%
Net Profit Margin
5.64%
↑ 5.64%
ROE
7.17%
↑ 7.17%
ROIC
11.15%
↑ 11.15%
Eurofins Scientific SE (ERFSF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Eurofins Scientific SE stock.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $3.42B | $3.31B | $3.21B | $3.30B |
| Cost of Revenue | $3.04B | $3.03B | $2.94B | $3.01B |
| Gross Profit | $374.50M | $279.90M | $266.90M | $290.40M |
| Gross Profit Ratio | $0.11 | $0.08 | $0.08 | $0.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $28.80M | $75.50M | $60.20M | $67.60M |
| Operating Expenses | $57.60M | $465.30M | $362.80M | $273.00M |
| Total Costs & Expenses | $3.04B | $3.03B | $2.94B | $3.01B |
| Interest Income | $15.00M | $0.00 | $40.40M | $1.20M |
| Interest Expense | $84.00M | $63.70M | $55.00M | $67.00M |
| Depreciation & Amortization | $329.20M | $353.60M | $310.70M | $312.80M |
| EBITDA | $702.20M | $633.50M | $632.80M | $534.10M |
| EBITDA Ratio | $0.21 | $0.19 | $0.18 | $0.18 |
| Operating Income | $374.50M | $279.90M | $266.90M | $290.40M |
| Operating Income Ratio | $0.11 | $0.08 | $0.08 | $0.09 |
| Other Income/Expenses (Net) | -$74.10M | -$76.20M | -$47.40M | $65.70M |
| Income Before Tax | $300.40M | $203.60M | $219.30M | $355.70M |
| Income Before Tax Ratio | $0.09 | $0.06 | $0.07 | $0.11 |
| Income Tax Expense | $81.40M | $46.60M | $68.90M | $58.30M |
| Net Income | $97.05M | $158.80M | $151.50M | $300.50M |
| Net Income Ratio | $0.03 | $0.05 | $0.05 | $0.09 |
| EPS | $1.14 | $0.83 | $0.79 | $1.56 |
| Diluted EPS | $1.13 | $0.80 | $0.76 | $1.52 |
| Weighted Avg Shares Outstanding | $193.00M | $192.03M | $192.90M | $192.52M |
| Weighted Avg Shares Outstanding (Diluted) | $195.20M | $197.61M | $198.20M | $197.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan